Literature DB >> 31723027

Genome-Wide Mutagenesis of Hepatitis C Virus Reveals Ability of Genome To Overcome Detrimental Mutations.

Deepak Singh1, Shalini Soni1, Shaheen Khan1, Aditya N Sarangi2, Ragothaman M Yennamalli3, Rakesh Aggarwal2, Naga Suresh Veerapu4.   

Abstract

To gain insight into the impact of mutations on the viability of the hepatitis C virus (HCV) genome, we created a set of full-genome mutant libraries, differing from the parent sequence as well as each other, by using a random mutagenesis approach; the proportion of mutations increased across these libraries with declining template amount or dATP concentration. The replication efficiencies of full-genome mutant libraries ranged between 71 and 329 focus-forming units (FFU) per 105 Huh7.5 cells. Mutant libraries with low proportions of mutations demonstrated low replication capabilities, whereas those with high proportions of mutations had their replication capabilities restored. Hepatoma cells transfected with selected mutant libraries, with low (4 mutations per 10,000 bp copied), moderate (33 mutations), and high (66 mutations) proportions of mutations, and their progeny were subjected to serial passage. Predominant virus variants (mutants) from these mutant libraries (Mutantl, Mutantm, and Mutanth, respectively) were evaluated for changes in growth kinetics and particle-to-FFU unit ratio, virus protein expression, and modulation of host cell protein synthesis. Mutantm and Mutantl variants produced >3.0-log-higher extracellular progeny per ml than the parent, and Mutanth produced progeny at a rate 1.0-log lower. More than 80% of the mutations were in a nonstructural part of the mutant genomes, the majority were nonsynonymous, and a moderate to large proportion were in the conserved regions. Our results suggest that the HCV genome has the ability to overcome lethal/deleterious mutations because of the high reproduction rate but highly selects for random, beneficial mutations.IMPORTANCE Hepatitis C virus (HCV) in vivo displays high genetic heterogeneity, which is partly due to the high reproduction and random substitutions during error-prone genome replication. It is difficult to introduce random substitutions in vitro because of limitations in inducing mutagenesis from the 5' end to the 3' end of the genome. Our study has overcome this limitation. We synthesized full-length genomes with few to several random mutations in the background of an HCV clone that can recapitulate all steps of the life cycle. Our study provides evidence of the capability of the HCV genome to overcome deleterious mutations and remain viable. Mutants that emerged from the libraries had diverse phenotype profiles compared to the parent, and putative adaptive mutations mapped to segments of the conserved nonstructural genome. We demonstrate the potential utility of our system for the study of sequence variation that ensures the survival and adaptation of HCV.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  genome viability; genome-wide mutagenesis; hepatitis C virus; quasispecies; reverse genetic analysis; tolerance

Year:  2020        PMID: 31723027      PMCID: PMC7000968          DOI: 10.1128/JVI.01327-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Protein structure prediction and analysis using the Robetta server.

Authors:  David E Kim; Dylan Chivian; David Baker
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  NGS QC Toolkit: a toolkit for quality control of next generation sequencing data.

Authors:  Ravi K Patel; Mukesh Jain
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

3.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

Review 4.  Natural history of hepatitis C.

Authors:  Rachel H Westbrook; Geoffrey Dusheiko
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

5.  Real-time detection system for quantification of hepatitis C virus genome.

Authors:  T Takeuchi; A Katsume; T Tanaka; A Abe; K Inoue; K Tsukiyama-Kohara; R Kawaguchi; S Tanaka; M Kohara
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

6.  Highly heterogeneous mutation rates in the hepatitis C virus genome.

Authors:  Ron Geller; Úrsula Estada; Joan B Peris; Iván Andreu; Juan-Vicente Bou; Raquel Garijo; José M Cuevas; Rosario Sabariegos; Antonio Mas; Rafael Sanjuán
Journal:  Nat Microbiol       Date:  2016-04-18       Impact factor: 17.745

7.  Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.

Authors:  Isla Humphreys; Vicki Fleming; Paolo Fabris; Joe Parker; Bodo Schulenberg; Anthony Brown; Charis Demetriou; Silvana Gaudieri; Katja Pfafferott; Michaela Lucas; Jane Collier; Kuan-Hsiang Gary Huang; Oliver G Pybus; Paul Klenerman; Eleanor Barnes
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

8.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

9.  Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.

Authors:  Donald B Smith; Jens Bukh; Carla Kuiken; A Scott Muerhoff; Charles M Rice; Jack T Stapleton; Peter Simmonds
Journal:  Hepatology       Date:  2014-01       Impact factor: 17.425

10.  Fast and accurate long-read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2010-01-15       Impact factor: 6.937

View more
  1 in total

Review 1.  HCV Replicon Systems: Workhorses of Drug Discovery and Resistance.

Authors:  Shaheen Khan; Shalini Soni; Naga Suresh Veerapu
Journal:  Front Cell Infect Microbiol       Date:  2020-06-30       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.